Absolute Bioavailability
Showing 1 - 25 of 3,772
Gaucher's Disease Type I Trial (Genz-112638, [14C]-Genz-112638)
Completed
- Gaucher's Disease Type I
- (no location specified)
Nov 16, 2023
NASH Trial in Nottingham (Aramchol)
Completed
- NASH
-
Nottingham, United KingdomQuotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nott
May 23, 2023
Asthma Trial in Ruddington (AZD4604 Inhalation Powder, 1 mg, [14C]AZD4604 Solution for Infusion 6 µg/mL (NMT 37.0 kBq/5 mL),
Not yet recruiting
- Asthma
- AZD4604 Inhalation Powder, 1 mg
- +2 more
-
Ruddington, United KingdomQuotient Sciences Limited
Nov 27, 2023
Healthy Volunteer, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Madison (EDG-5506 Tablet, Radiolabeled EDG-5506
Recruiting
- Healthy Volunteer
- +7 more
- EDG-5506 Tablet
- +2 more
-
Madison, WisconsinLabcorp Clinical Research Unit, Inc.
Feb 7, 2023
Healthy Volunteers Trial in Leeds (E7386 Tablet, (14C)E7386 Capsule, (14C)E7386)
Recruiting
- Healthy Volunteers
- E7386 Tablet
- +2 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Oct 31, 2022
Healthy Trial in Madison ([14C] Selpercatinib, Selpercatinib)
Completed
- Healthy
- [14C] Selpercatinib
- Selpercatinib
-
Madison, WisconsinLabCorp CRU, Inc.
Nov 21, 2022
Healthy Volunteer Trial in Ruddington (Capivasertib film-coated tablet, 200 mg, [14C]AZD5363 (Capivasertib))
Completed
- Healthy Volunteer
- Capivasertib film-coated tablet, 200 mg
- [14C]AZD5363 (Capivasertib)
-
Ruddington, United KingdomResearch Site
Jul 21, 2022
Healthy Trial in Singapore (LY3209590 (SC), LY3209590 (IV))
Recruiting
- Healthy
- LY3209590 (SC)
- LY3209590 (IV)
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 23, 2022
Healthy Trial in Nottingham (GLPG3667 capsule, [14C]-GLPG3667 solution for infusion, [14C]-GLPG3667 capsule)
Completed
- Healthy
- GLPG3667 capsule
- +2 more
-
Nottingham, United KingdomQuotient Sciences Limited
Jun 29, 2022
Non-alcoholic Steatohepatitis, Type 2 Diabetes (T2DM), Chronic Kidney Disease Trial in Ruddington (cotadutide solution for
Completed
- Non-alcoholic Steatohepatitis
- +2 more
- cotadutide solution for injection
-
Ruddington, United KingdomResearch Site
Sep 30, 2022
Healthy Trial in Madison (LY3502970, [14C]-LY3502970)
Not yet recruiting
- Healthy
-
Madison, WisconsinCovance Clinical Research Inc
Oct 10, 2023
Healthy Subjects Trial in Dilworth (FL-101-Intravenous, FL-101-Subcutaneous)
Completed
- Healthy Subjects
-
Dilworth, MinnesotaAxis Clinicals
May 29, 2022
Healthy Volunteers Trial in Nottingham ([14C]-GDC-9545, GDC-9545 Solution for Infusion, GDC-9545/F12 Capsule)
Completed
- Healthy Volunteers
- [14C]-GDC-9545
- +3 more
-
Nottingham, United KingdomQuotient Sciences
Jan 17, 2023
Healthy Trial in Madison ([¹4C]-LOXO-783, LOXO-783)
Not yet recruiting
- Healthy
-
Madison, WisconsinFortrea Clinical Research
Oct 23, 2023
Healthy Trial ([¹4C] BI 685509 formulation 1, [¹4C] BI 685509 formulation 2, BI 685509 formulation 3)
Not yet recruiting
- Healthy
- [¹⁴C] BI 685509 formulation 1
- +2 more
- (no location specified)
Aug 23, 2022
Healthy Trial in Madison (LY3537982, [¹4C]-LY3537982)
Not yet recruiting
- Healthy
-
Madison, WisconsinLabcorp Clinical Research Unit Inc.
Jun 4, 2023
Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)
Not yet recruiting
- Healthy
- BI 1810631 (C-14) formulation 1
- +2 more
- (no location specified)
May 25, 2023
Healthy Volunteers Trial in Lincoln (TAK-906 Oral Capsule, [14C]-TAK-906 Intravenous Infusion, [14C]-TAK-906 Oral Solution)
Completed
- Healthy Volunteers
- TAK-906 Oral Capsule
- +2 more
-
Lincoln, NebraskaCelerion
Dec 15, 2021
Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)
Completed
- Healthy Subjects
- Quizartinib dihydrochloride
- 14C-Quizartinib solution for infusion
-
Nottingham, United KingdomQuotient Sciences
Apr 15, 2022
Healthy Trial in Groningen (ACT-777991 (SAD), ACT-777991 (MAD), Placebo (SAD))
Completed
- Healthy
- ACT-777991 (SAD)
- +7 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Jun 17, 2022
Healthy Volunteers Trial in Baltimore (BIIB122 (DNL151), [14C] BIIB122 ([14C] DNL151))
Completed
- Healthy Volunteers
- BIIB122 (DNL151)
- [14C] BIIB122 ([14C] DNL151)
-
Baltimore, MarylandPharmaron CPC
Nov 9, 2021
Type 2 Diabetes, Healthy Subjects Trial in Nottingham (Sotagliflozin (SAR439954), 14C-microtracer, Charcoal)
Completed
- Type 2 Diabetes Mellitus
- Healthy Subjects
- Sotagliflozin (SAR439954)
- +2 more
-
Nottingham, United KingdomInvestigational site number 8260001
Apr 21, 2022
Healthy Trial (BI 690517 (C-14), BI 690517)
Not yet recruiting
- Healthy
- BI 690517 (C-14)
- BI 690517
- (no location specified)
Aug 24, 2022